Correct - Expected timeline for approval is April 2021.
Everything is now hinging on this approval happening as expected.
Nuvaring generic is maybe the end of 2021 but it's noticeable that Mayne don't talk it up like they used to. All the hype and hope has been transferred to Nextstellis. It's an all or nothing play with Scott Richards just crossing his fingers that a rabbit comes out of the hat.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 810 | $5.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.15 | 2033 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |